|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.580 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -4.865% | -8.180% | -4.449% | -15.676% | -24.820% |
| ROAE (%) | -6.813% | -12.085% | -6.436% | -21.765% | -35.090% |
| Return on Capital Employed (%) | -6.030% | -10.036% | -4.956% | -18.631% | -33.089% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 61.784% | 64.234% | 75.387% | 66.692% | 100.000% |
| EBITDA Margin (%) | -35.255% | -50.042% | -3.064% | -182.522% | -198.459% |
| Pre-tax Profit Margin (%) | -63.626% | -74.423% | -20.154% | -223.371% | -230.881% |
| Net Profit Margin (%) | -34.234% | -53.556% | -17.818% | -115.550% | -203.096% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 3.925 X | 4.292 X | 6.017 X | 6.960 X | 18.542 X |
| Quick Ratio (X) | 3.907 X | 4.247 X | 5.949 X | 6.900 X | 18.542 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 28.972% | 27.439% | 24.535% | 22.006% | 7.507% |
| Total Debt / Total Assets (%) | 15.153% | 15.329% | 15.849% | 14.442% | 0.762% |
| Net Debt / Total Assets (%) | 8.261% | 7.385% | -1.605% | -0.816% | -4.230% |
| Total Debt / Shareholders' Funds (%) | 19.936% | 22.794% | 23.281% | 20.583% | 1.035% |
| Long Term Debt / Shareholders' Funds (%) | 18.061% | 20.982% | 21.762% | 19.369% | 0.415% |
| Net Debt / Shareholders' Funds (%) | 10.869% | 10.982% | -2.358% | -1.164% | -5.747% |
| Net Cash / (Debt) ($) | (25.027M) | (24.632M) | 6.043M | 3.113M | 19.005M |
| Net Cash / (Debt) per share ($) | (0.063) | (0.062) | 0.015 | 0.008 | 0.048 |
| Total Debt / Capital Employed (%) | 17.878% | 17.672% | 17.544% | 15.758% | 0.791% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 29.257 Day | 42.013 Day | 34.398 Day | 36.838 Day | N/A |
| Receivables Turnover (Day) | 90.298 Day | 92.856 Day | 32.042 Day | 70.347 Day | 117.817 Day |
| Payables Turnover (Day) | 32.045 Day | 13.222 Day | 0.932 Day | 1.108 Day | N/A |
| Remarks: | Real time quote last updated: 11/11/2024 10:16 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -5,606,000 |
| %Change | -14.673% |
| EPS / (LPS) | HKD -0.014 |
| NBV Per Share ($) | HKD 0.563 |